Amifitadine
Amifitadine (also known as EB-1530 or GR-1530) is a drug that is used in scientific research. It is a triple reuptake inhibitor that affects the neurotransmitters serotonin, norepinephrine, and dopamine.
Pharmacology[edit | edit source]
Amifitadine is a triple reuptake inhibitor, meaning it inhibits the reuptake of three neurotransmitters: serotonin, norepinephrine, and dopamine. This increases the amount of these neurotransmitters in the brain, which can have various effects on mood, cognition, and other neurological functions.
History[edit | edit source]
Amifitadine was first developed by the pharmaceutical company Euthymics Bioscience, which later became known as Neurovance. The drug was initially investigated as a potential treatment for depression and attention deficit hyperactivity disorder (ADHD).
Clinical trials[edit | edit source]
In clinical trials, amifitadine has been shown to have potential as a treatment for depression and ADHD. However, further research is needed to fully understand its efficacy and safety profile.
See also[edit | edit source]
Amifitadine Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD